Literature DB >> 12197858

Major depressive disorder in Parkinson's disease: a register-based study.

Flemming M Nilsson1, Lars V Kessing, Tine M Sørensen, Per K Andersen, Tom G Bolwig.   

Abstract

OBJECTIVE: To investigate whether patients with Parkinson's disease (PD) were at an increased risk of developing major depression compared with patients having other medical illnesses with a comparable degree of disability.
METHOD: Case register linkage study of Danish Psychiatric Central Register (DPCR)and Danish National Hospital Register (DNHR). Three study cohorts were identified: all patients with PD, osteoarthritis, and diabetes. The rate of discharge diagnosis of depression on re-admission was estimated using competing risks models in survival analyses. The rates for patients with PD were compared with those of patients with osteoarthritis, and diabetes.
RESULTS: The study sample identified 211 245 patients in the hospital registers with one of the index diagnoses. An increased incidence of developing depression was found for women and men throughout their lifetime when this incidence was compared with the control groups.
CONCLUSION: The findings support the hypothesis that depression in patients with PD is a consequence of brain dysfunction. Copyright Blackwell Munksgaard 2002.

Entities:  

Mesh:

Year:  2002        PMID: 12197858     DOI: 10.1034/j.1600-0447.2002.02229.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  27 in total

1.  Comorbid chronic illness and the diagnosis and treatment of depression in safety net primary care settings.

Authors:  Chizobam Ani; Mohsen Bazargan; David Hindman; Douglas Bell; Michael Rodriguez; Richard S Baker
Journal:  J Am Board Fam Med       Date:  2009 Mar-Apr       Impact factor: 2.657

Review 2.  Epidemiology of Parkinson's disease.

Authors:  Guido Alves; Elin Bjelland Forsaa; Kenn Freddy Pedersen; Michaela Dreetz Gjerstad; Jan Petter Larsen
Journal:  J Neurol       Date:  2008-09       Impact factor: 4.849

3.  The Gender-Biased Effects of Intranasal MPTP Administration on Anhedonic- and Depressive-Like Behaviors in C57BL/6 Mice: the Role of Neurotrophic Factors.

Authors:  Marissa Giovanna Schamne; Josiel Mileno Mack; Morgana Moretti; Filipe Carvalho Matheus; Roger Walz; Laurence Lanfumey; Rui Daniel Prediger
Journal:  Neurotox Res       Date:  2018-05-28       Impact factor: 3.911

4.  The effect of unilateral subthalamic nucleus deep brain stimulation on depression in Parkinson's disease.

Authors:  Elizabeth L Birchall; Harrison C Walker; Gary Cutter; Stephanie Guthrie; Allen Joop; Raima A Memon; Ray L Watts; David G Standaert; Amy W Amara
Journal:  Brain Stimul       Date:  2016-12-27       Impact factor: 8.955

5.  [Relation between certain diseases and frequency of depression in geriatric patients].

Authors:  V Zietemann; P Zietemann; R Weitkunat; A Kwetkat
Journal:  Nervenarzt       Date:  2007-06       Impact factor: 1.214

6.  The bidirectional longitudinal relationship between insomnia, depression and anxiety in patients with early-stage, medication-naïve Parkinson's disease.

Authors:  Sonja Rutten; Chris Vriend; Ysbrand D van der Werf; Henk W Berendse; Daniel Weintraub; Odile A van den Heuvel
Journal:  Parkinsonism Relat Disord       Date:  2017-02-01       Impact factor: 4.891

Review 7.  Neuropsychiatric aspects of Parkinson's disease.

Authors:  Anna Nagy; Anette Schrag
Journal:  J Neural Transm (Vienna)       Date:  2019-05-29       Impact factor: 3.575

8.  Social anhedonia in major depressive disorder: a symptom-specific neuroimaging approach.

Authors:  Verena Enneking; Pia Krüssel; Dario Zaremba; Katharina Dohm; Dominik Grotegerd; Katharina Förster; Susanne Meinert; Christian Bürger; Fanni Dzvonyar; Elisabeth J Leehr; Joscha Böhnlein; Jonathan Repple; Nils Opel; Nils R Winter; Tim Hahn; Ronny Redlich; Udo Dannlowski
Journal:  Neuropsychopharmacology       Date:  2018-11-27       Impact factor: 7.853

Review 9.  Psychiatric aspects of Parkinson's disease--an update.

Authors:  Anette Schrag
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

10.  Effects of Agmatine on Depressive-Like Behavior Induced by Intracerebroventricular Administration of 1-Methyl-4-phenylpyridinium (MPP(+)).

Authors:  Morgana Moretti; Vivian Binder Neis; Filipe Carvalho Matheus; Mauricio Peña Cunha; Priscila Batista Rosa; Camille Mertins Ribeiro; Ana Lúcia S Rodrigues; Rui Daniel Prediger
Journal:  Neurotox Res       Date:  2015-07-09       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.